Medications

FDA approves mavenclad for treating multiple sclerosis

(HealthDay)—Mavenclad (cladribine) tablets were approved to treat adult patients with relapsing-remitting and active secondary progressive multiple sclerosis (MS) who have inadequately responded to or cannot tolerate an ...

Neuroscience

How the brain fights off fears that return to haunt us

Neuroscientists at The University of Texas at Austin have discovered a group of cells in the brain that are responsible when a frightening memory re-emerges unexpectedly, like Michael Myers in every "Halloween" movie. The ...

Medications

Combination therapy might be beneficial in schizophrenia

Combining certain types of two antipsychotic agents in the maintenance treatment of schizophrenia is associated with a lower risk of relapse than using monotherapy. This is suggested in a paper published by researchers at ...

Diseases, Conditions, Syndromes

Impact of acne relapses on quality of life and productivity

In a study of teenagers and adults suffering from acne who consulted their dermatologist, the acne relapse rate was 44 percent (39.9 percent of ≤20-year-olds and 53.3 percent of >20-year-olds).

Medical research

Stem cell transplant slows progression of multiple sclerosis

(HealthDay)—For patients with relapsing-remitting multiple sclerosis (MS), nonmyeloablative hematopoietic stem cell transplantation (HCST) is associated with prolonged time to disease progression compared with disease-modifying ...

page 1 from 22